<DOC>
	<DOC>NCT01206946</DOC>
	<brief_summary>The hypothesis of the study is that administration of antenatal steroid to women at high risk of preterm birth after 34 weeks of gestation would reduce the risk of respiratory complications, specifically Respiratory Distress Syndrome (RDS) or Transient Tachypnea of the Newborn (TTN) in late preterm babies.</brief_summary>
	<brief_title>Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
	<mesh_term>Transient Tachypnea of the Newborn</mesh_term>
	<mesh_term>Tachypnea</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Women between 34 0/7 36 6/7 weeks of gestation High risk of preterm birth Multiple births Fetal congenital malformations A course of steroids within 2 weeks of randomization Multiple courses of steroids Chorioamnionitis Non reassuring fetal heart rate Obstetrical indication of delivery Active bleeding Pregnancy related hypertensive disorders Uncontrolled diabetes</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Respiratory distress</keyword>
	<keyword>Antenatal steroids</keyword>
	<keyword>late preterm</keyword>
</DOC>